The Abstract: While biotechnology in the West is deeply rooted, it is only coming into its own in Asia. The fast growing Asian biotech sector was seen contributing USD 4965 billion in 2008 from a total of USD 88647 billionfrom a Global Industry Performance perspective. Eight pharmaceutical markets in South East Asia, including Malaysia, are developing aggressively and projected to have a total market value of USD 77.4 billion by 2016.
This discussion by a panel of experts will delve into the opportunities, challenges, global issues and the growing importance of Asiarelative to the West positioning in the biotechnology market place.Each panelistwill talk about:
- Breakthroughs in the East and West.
- What factors are driving Western players to the East?
- How can the East contribute to development/enhancement of biotechnology in the West?
- Potential areas for collaboration between East and West
The Panel: Tentatively, the following panelists are proposed:
- Y Bhg. Tan Sri Datuk Dr. Ahmad Zaharudin Bin Idrus
Chairman, Malaysian Biotechnology Corporation Sdn Bhd - Dr. Andrew Powell
Chief Executive Officer, Asia BioBusiness - Dr. Sakarindr. Bhumiratana
President, King Mongkut’s University of Technology Thonburi, Thailand
The Chairperson: Andrew Marshall, Scientific American
Andrew Marshall has been Editor of Nature Biotechnology since 2000. In the intervening period, the journal’s impact factor has risen from 11.4 to 29.5. As well as frequently speaking on biotechnology issues at international meetings, he regularly heads and organizes conferences and symposia for Nature Publishing Group, including the acclaimed SciCafe series that brings together industry R&D leaders, investors and up-and-coming academic investigators in Boston, San Francisco and London. He has 19 years of experience in scientific publishing and was previously Editor of Current Opinion in Biotechnology from 1992 to 1996. He has written over 150 articles and editorials on science and technology for the popular media, including The Economist and Popular Science, and for trade publications. In 2003, he launched Bioentrepreneur (www.nature.com/bioent), a free-access web portal that provides practical information and advice on the challenges of starting a biotechnology company. He obtained his PhD and postdoctoral experience in molecular biology and microbiology at King’s College London. He is the recipient of the Helen White Prize.
The Program
1.00 pm – Sponsor’s Welcome Address
1.10 pm – Lunch
1.45 pm – Power Lunch Panel Discussion
2.15 pm – Q & A Session
2.25 pm – End
